» Articles » PMID: 23325925

Sirtuin Deacylases: a Molecular Link Between Metabolism and Immunity

Overview
Journal J Leukoc Biol
Date 2013 Jan 18
PMID 23325925
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Lysine deacetylation by the NAD(+)-dependent family of sirtuins has been recognized as an important post-translational modification regulating a wide range of cellular processes. These lysine deacetylases have attracted much interest based on their ability to promote survival in response to stress. Sirtuins require NAD(+) for their enzymatic activity, suggesting that these enzymes may represent molecular links between cell metabolism and several human disorders, including diabetes and cancer. Inflammation represents a pathological situation with clear connections to metabolism and aging in humans, raising the possibility that sirtuins may also play an important role during a normal and/or a pathological immune response. A growing body of data has confirmed the immunomodulatory properties of sirtuins, although often with contrasting and opposing conclusions. These observations will be summarized herein and the possible strategies that may lead to the development of novel therapeutic approaches to treat inflammation briefly discussed.

Citing Articles

The dual role of sirtuins in cancer: biological functions and implications.

Yu L, Li Y, Song S, Zhang Y, Wang Y, Wang H Front Oncol. 2024; 14:1384928.

PMID: 38947884 PMC: 11211395. DOI: 10.3389/fonc.2024.1384928.


Insights into the modulation of bacterial NADase activity by phage proteins.

Yin H, Li X, Wang X, Zhang C, Gao J, Yu G Nat Commun. 2024; 15(1):2692.

PMID: 38538592 PMC: 10973363. DOI: 10.1038/s41467-024-47030-z.


Sirtuins and Metabolism Biomarkers in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: a Correlation Study with Clinical Outcomes and Cognitive Impairments.

Foolad F, Samadi-Bahrami Z, Khodagholi F, Nabavi S, Moore G, Javan M Mol Neurobiol. 2023; 61(6):3442-3460.

PMID: 37995076 DOI: 10.1007/s12035-023-03778-x.


A new strategy for cardiac protection.

Bouhamida E, Chaudhry H Elife. 2023; 12.

PMID: 37917118 PMC: 10622142. DOI: 10.7554/eLife.93239.


SIRT2 inhibition protects against cardiac hypertrophy and ischemic injury.

Yang X, Chang H, Tatekoshi Y, Mahmoodzadeh A, Balibegloo M, Najafi Z Elife. 2023; 12.

PMID: 37728319 PMC: 10558204. DOI: 10.7554/eLife.85571.